In the chemokine signaling and cytokine–cytokine receptor interaction pathways, CXCL6 showed greater levels while CCL3L1, CCL19, CCL25, and PPBP showed decreased levels in CKD patients than healthy controls. The gene discussed is CXCL6; the disease is chronic kidney disease.